Khiron Life Sciences Corp.
KHRN.V
Toronto Stock Exchange Ventures0.04
CAD
- -
- -
Khiron Life Sciences Corp.
KHRN.V
(Toronto Stock Exchange Ventures)
Recent
price
0.04
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Khiron Life Sciences Corp. functions as a specialized medical cannabis and healthcare services enterprise, concentrating its efforts across Latin America and Europe. The company strategically engages through its distinct Health Services, Medical Cannabis Products, and Wellbeing Products divisions. Its primary focus is on generating demand for high-value medical cannabis through its patient-centric approach and extensive clinic operations, rather than direct cultivation and extraction activities, which have been scaled back in Colombia to enhance its business-to-consumer model. Khiron maintains a widespread network of medical facilities, including Zerenia clinics and satellite sites, along with telemedicine platforms, that provide a range of health and medical services designed to facilitate medical cannabis prescriptions and patient monitoring. Furthermore, it is involved in the distribution and export of both THC and CBD medical cannabis products, and develops CBD-infused cosmeceuticals under its Kuida brand. Khiron was established in 2012 and maintains its headquarters in Vancouver, Canada.